Lv2
120 积分 2025-01-08 加入
Machine learning-assisted optimization of dietary intervention against dementia risk
8小时前
已完结
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
1个月前
已完结
An updated patent review of small molecule KCNT1 inhibitors (2022 ‒ 2024)
1个月前
已完结
Artificial intelligence in drug development
2个月前
已完结
Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
2个月前
已完结
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
2个月前
已完结
Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
3个月前
已完结
Study Identifies Benefits and Risks of GLP-1 Drugs Across 175 Health Outcomes
3个月前
已完结
Tau-targeting therapies for Alzheimer disease: current status and future directions
3个月前
已完结
Mapping the effectiveness and risks of GLP-1 receptor agonists
4个月前
已完结
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
Current management of diabetes mellitus and future directions in care
皖公网安备34019202002308
